| Serial Number | 90424617 |
| Word Mark | IGEG |
| Filing Date | Tuesday, December 29, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 7, 2022 |
| Registration Number | 6750023 |
| Registration Date | Tuesday, June 7, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 15, 2022 |
| Goods and Services | Pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use |
| Goods and Services | Licensing of intellectual property rights; licensing of industrial property rights |
| Goods and Services | Medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical advisory services; medical laboratory analysis services relating to the treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology |
| Goods and Services | Development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; research and development of pharmaceuticals in the fields of oncology, immunology and immuno-oncology; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies; research and development in the field of recombinant proteins and antibodies for therapeutic and prophylactic use; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new therapeutic proteins and antibodies; development of pharmaceuticals, pharmaceutical ingredients, and antibodies; scientific study and research in the field of developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical services, namely, developing tumor targeting platform technologies; scientific research in the nature of scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the fields of oncology, immunology and immuno-oncology; pharmaceutical product development and evaluation services; pharmaceutical research and development; technical research in the field of pharmaceutical studies; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services in the fields of biotechnology and pharmaceutical research; consulting services for others in the field of design, planning, and implementation of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 20, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 20, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Epsilogen Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | London NW10NH GB |
| Party Name | Epsilogen Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London NW10NH GB |
| Party Name | Epsilogen Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London NW10NH GB |
| Event Date | Event Description |
| Tuesday, June 7, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, June 7, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Friday, April 29, 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, April 1, 2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Tuesday, February 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 15, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 26, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 10, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, January 10, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 10, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, January 10, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, January 10, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, January 10, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 28, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 28, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 23, 2021 | ASSIGNED TO LIE |
| Tuesday, December 21, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 28, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 28, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, June 28, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, June 28, 2021 | ASSIGNED TO EXAMINER |
| Saturday, March 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, January 1, 2021 | NEW APPLICATION ENTERED IN TRAM |